Log inSign up
Reading a stock page
  • The tabs show the price chart, results, shareholding, events and news for this one company.
  • The Signal Score sums up trend, momentum and quality from past data. It is a description, not a forecast.
  • Every figure names its source. "Official" means it came from NSE or BSE filings.
  • Use the star to watch the stock, or Add to portfolio to record a trade.

Prices during market hours are delayed by up to 15 minutes. Nothing here is a recommendation to buy or sell.

« Dashboard

ARTEMISMED ☆ BSE also on NSE

Artemis Medicare Services Limi · code 542919 · INE025R01021 · Pharma & Healthcare · series B · Daily price history

339.20 -4.15 (-1.21%) close on 19 Nov 2026
Official NSE & BSE Auto-Sync: Checking Overview, Financials, Technicals, Shareholding & Events in the background...
82

ISA Signal Score: Strong setup

Buy candidate: research it further. Based on prices to 2026-11-19. Confidence 100%.

Trend100
Momentum79
52-week range83
Volume73
Risk62
Fundamentals81

Working for it

  • Price is above its 20-day average
  • Price is above its 50-day average
  • Price is above its 200-day average (long-term uptrend)
  • 50-day average is above the 200-day average
  • RSI 64: healthy strength
  • More volume on up days than down days (accumulation)

Red flags

  • Thinly traded: average daily turnover is low, so entering or exiting can be hard

Measured reference levels (not forecasts): 20-day low 283.65, 52-week high 366.35, typical daily move 12.00, two typical moves below price 315.21.

A rule-based reading of price, volume and filed numbers. It is information, not investment advice, and it can be wrong. Do your own research.

At a glance

Five quick readings from results and prices. A starting point for your own research, not advice.
QualityAverageROE 11.7%, ROCE 14.4%, debt 0.28x equity
GrowthFastSales 18.1%, profit 35.3% a year over 4 years
ValuationFairP/E 51.8 vs sector median 44.6
MomentumStrongAbove its 200-day average, beat NIFTY 50 by 19.9 points
RiskMediumSwings 38% a year, fell up to 29% from a peak, beta 0.80

Smart Investor Tips: ARTEMISMED

Constructive Setup (Trend + Fundamentals Aligned)

Actionable Insights & Positives

  • Confirmed uptrend: trading above both rising 50-day (Rs 321.18) and 200-day (Rs 276.90) averages.
  • Strong earnings compounding: net profit grew at 35.3% CAGR over 4 years.
  • Tip: Click the star button above to add this stock to your Watchlist and set a target "Buy below" alert price.

BSE Authentic Bhavcopy & Cross-Exchange Check No API Key

Runs authentic BSE price & volume verification (latest BSE Bhavcopy snapshot, split-adjusted 52W High/Low, 20/50/200 DMA alignment, and 20-day volume trend, plus cross-listed NSE MCP check when shared by ISIN).

Algorithmic Momentum Prediction & Optimal Entry PriceBUY / POSITIVE IN ZONE (Score 85/100)

Strong technical, volume & cash-flow setup. Best support area: Rs 316.36 – Rs 335.81 (Ideal entry ~Rs 326.09). Stagger 50% near Rs 335.81 and 50% near Rs 316.36. Risk level / review below Rs 259.00; Swing Target Rs 446.85 (R:R 1.8x).

Optimal Support areaTranche 1 (50%)Tranche 2 (50%)Risk level / ReviewLevel 1 (Swing)Level 2 (Breakout)Risk : Reward
Rs 316.36 – Rs 335.81
Ideal ~Rs 326.09
Rs 335.81 Rs 316.36 Rs 259.00
ATR 3.5%
Rs 446.85 Rs 527.36 1 : 1.8
RSI 73 · Vol 1.58x
1M 3M 6M 1Y 3Y ALL Investment checklist Download CSV 6M change +24.4% · high 378.40 · low 253.60 · max drawdown -22.6%

Live Candlestick & TradingView Chart (ARTEMISMED)

MARKET CLOSED - EOD SNAPSHOT
Style:  Timeframe:  Overlays:

Key figures results FY26, price 19 Nov

P/E51.8sector median 44.6
P/B-price / book value
EPSRs 6.55grew 28.5% a year
Dividend yield-from saved dividend events
Debt to equity0.28xnet debt Rs 262 Cr
Sales growth18.1%a year over 4 years
Profit growth35.3%a year over 4 years
Operating margin17.4%net margin 9.6%

From the official NSE results filings, consolidated. P/E uses the last full year's EPS, PEG 1.47. See all years.

Company Debt, Borrowings & Cash Flow Health (Official FY26 Consolidated Filing)

Auto-extracted from official NSE/BSE XBRL Balance Sheet & Cash Flow statements (Rs Crore).

Strong Balance Sheet & Cash Flow · Score 93/100
Total Debt / Loans Rs 262 Cr Reduced Rs 28.0 Cr YoY
Cash & Bank Balances - Liquid cash & equivalents
Net Debt (Loans − Cash) Rs 262 Cr 18.3% of total assets
Debt to Equity & Interest Cover 0.28x D/E Interest cover: 6.0x EBIT
Operating Cash Flow (OCF) Rs 132 Cr OCF/PAT conversion: 127%
Free Cash Flow (FCF) - OCF minus Capex
  • Low Debt-to-Equity (0.28x).
  • De-leveraging: reduced total debt by Rs 28.0 Cr YoY.
  • Strong loan interest coverage (6.0x EBIT/Interest).
  • High earnings quality: Operating Cash Flow converts 193% of net profit into real cash.

About Artemis Medicare Services Limi

No company description saved yet. Use Profile below to read about this company.

Listed on BSE NSE

Market capNot available
First listed23 Jan 2020BSE not available · NSE 23 Jan 2020
Face valueRs 1
Book valueNot available
ROENot availableReturn on equity
ROCENot availableReturn on capital employed

NSE: listing date, face value

Profile completeness2 of 8Missing: description, industry, share count, book value, ROE, ROCE

Not checked yet.

Profile, History and Financial records open a web search for this company in a new tab.

Shareholding

Promoters and group 58.39% 0.00 pp, public 41.61%, as on 30 Sep 2026. Holder names and history

Day range337.65 to 349.10Open 349.00
52-week high378.40 -10.4% from high (25 Sep 2026)
52-week low202.85 +67.2% from low (13 Apr 2026)
Volume8,763 0.7x the 20-day average
RSI (14)64 neutral
Volatility (30d)38.8%annualised
202.85
378.40

Returns

1W+7.0%
1M+12.5%
3M+5.6%
6M+21.3%
1Y+17.9%
YTD+25.2%
3Y a year+27.1%
5Y a year+57.3%

Against the NIFTY 50

PeriodARTEMISMEDNIFTY 50Difference
1M+12.5%+11.5% +1.0 pts
3M+5.6%+5.3% +0.3 pts
6M+21.3%+7.9% +13.5 pts
1Y+17.9%-2.1% +19.9 pts

Risk over the past year

Volatility38%medium
Deepest fall-28.7%from a peak
Beta0.80moves less than the index
Best day+7.9%29 Jul 2026
Worst day-9.4%03 Feb 2026
Up days50%of sessions

Returns use closing prices. Bonus issues and splits are adjusted automatically when detected. Beta compares daily moves with the NIFTY 50 over 246 shared sessions.

AI analysis

Company turnover, products, risks and entry ideas, written by the AI provider you set up in Settings.

Open AI analysis

🛡 Forensic Financial Health: Piotroski F-Score & 3-Step DuPont ROE Decomposition

Institutional balance-sheet quality, earnings-to-cash conversion, and ROE driver breakdown from official XBRL filings.

Piotroski F-Score: 8 / 9 · Fortress Balance Sheet
3-Step DuPont ROE Identity: Balanced Profitability & Efficiency
Net Margin: 9.6% × Asset Turnover: 0.76x × Equity Multiplier: 1.53x = ROE 11.7%
✓ Positive Net Profit (PAT > 0) Rs 104 Cr
✓ Positive Operating Cash Flow (OCF > 0) Rs 132 Cr
✓ High Cash Conversion (OCF >= 85% of PAT) 127% conversion
✓ Improving Return on Assets (ROA YoY) 7.3% vs 6.0%
✓ Conservative / Decreasing Debt-to-Equity 0.28x (prev 0.35x)
✓ Healthy Balance Sheet Asset Coverage 6.16x
⚠ Institutional Return on Equity (ROE >= 14%) 11.7%
✓ Stable / Expanding Profit Margin YoY 9.6% vs 8.8%
✓ Asset Turnover Efficiency (Sales / Assets) 0.76x

Quarterly Results (Last 8 Quarters — QoQ & YoY Acceleration) Rs crore

Rs crore Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026 Sep 2026
Sales / Revenue 227240255275272279287311
Sales QoQ % -3.3%+5.8%+6.3%+7.8%-1.1%+2.6%+2.9%+8.4%
Operating Profit 36.837.041.050.045.051.057.054.0
Operating Margin (OPM %) 16.2%15.4%16.1%18.2%16.5%18.3%19.9%17.4%
Net Profit (PAT) 20.823.021.030.022.030.031.031.0
Profit QoQ % -7.9%+10.7%-8.7%+42.9%-26.7%+36.4%+3.3%+0.0%
Profit YoY % +80.5%+65.2%+24.1%+33.0%+5.9%+30.4%+47.6%+3.3%
Net Margin % 9.2%9.6%8.2%10.9%8.1%10.8%10.8%10.0%

Sales and profit Rs crore, consolidated

Sales growth+18.1%a year, 4Y
Profit growth+35.3%a year, 4Y
EPS growth+28.5%a year, 4Y
Avg ROE10.8%5 years

Profit and loss

Rs croreFY22FY23FY24FY25FY26
Sales5557378799371,081
Sales growth-+32.9%+19.1%+6.7%+15.4%
Operating profit68.094.0133152188
Operating margin12.3%12.7%15.1%16.2%17.4%
Other income3.007.347.3533.027.0
Interest12.019.731.332.028.0
Depreciation22.031.040.345.048.0
Profit before tax37.050.668.5108139
Tax rate16.0%24.9%28.2%24.0%25.0%
Net profit31.035.949.182.0104
Profit growth-+15.8%+36.9%+66.9%+26.8%
Net margin5.6%4.9%5.6%8.8%9.6%
EPS (Rs)2.402.893.626.006.55

Balance sheet

Rs croreFY22FY23FY24FY25FY26
Equity (net worth)359403448838935
Borrowings201242254290262
Cash-50.961.3--
Total assets7109059721,3571,429
Debt to equity0.56x0.60x0.57x0.35x0.28x

Debt, Loans, Cash Flow & Working Capital

Rs croreFY22FY23FY24FY25FY26
Operating Cash Flow (OCF)60.0127109156132
Capital Expenditure (Capex)-14672.6--
Free Cash Flow (FCF = OCF - Capex)--19.336.3--
OCF / Net Profit Conversion1.94x3.54x2.22x1.90x1.27x
Total Borrowings / Loans201242254290262
Cash & Bank Balances-50.961.3--
Trade Receivables (Cr)-93.394.8--
Receivable Days-46.17x39.39x--
Inventories (Cr)-14.010.1--
Inventory Days-6.92x4.19x--

Returns on capital

Rs croreFY22FY23FY24FY25FY26
ROE8.6%9.4%11.5%12.7%11.7%
ROCE8.7%11.2%13.4%14.6%14.4%
Interest cover4.08x3.57x3.19x4.38x5.96x

Read from the official annual results filed with NSE (XBRL), consolidated figures. ROE uses average equity of the year and the year before when both are saved, ROCE uses profit before interest and tax over total assets less current liabilities. EPS is per today's share. Check the annual report before investing.

Compared with its sector Pharma & Healthcare

StockPriceDay1 yearMkt cap (Cr)P/EP/BROENet margin
ALIVUSALIVUS LIFE SCIENCES LIMITED 1,449.85 +0.3% - 17,768 37.7 7.6 20.2% 20.6%
CAPLIPOINTCAPLIN POINT LABORATORIES LTD. 2,085.40 -0.0% - 15,839 34.6 6.8 19.7% 27.0%
ASTRAZENASTRAZENECA PHARMA INDIA LTD. 6,120.45 +1.9% - 15,301 94.7 21.5 22.7% 12.5%
AARTIPHARMAarti Pharmalabs Limited 1,024.80 +1.3% - 9,287 42.8 5.3 12.3% 11.7%
BLUEJETBlue Jet Healthcare Limited 516.80 -0.2% - 8,964 54.7 10.6 19.4% 23.0%
CIPLACIPLA LTD. 1,416.00 -0.3% - - 29.5 - - 13.7%
ALKEMAlkem Laboratories Limited 5,145.00 -1.1% - - 26.7 - 17.0% 16.0%
DIVISLABDIVIS LABORATORIES LTD. 11,178.00 +1.0% - - 115.6 - 15.3% 24.3%
WOCKPHARMAWOCKHARDT LTD. 2,186.60 +7.9% - - - - - -
RUBICONRUBICON RESEARCH LIMITED 1,726.00 +3.9% - - - - - -
APOLLOHOSPAPOLLO HOSPITALS ENTERPRISE LT 8,744.80 -0.8% - - 64.8 - 21.1% 7.9%
RAINBOWRainbow Children's Medicare Li 1,241.45 -1.3% - - - - - -
Sector median- 44.67.617.0%

The 12 largest of 80 stocks in this sector on BSE, by market cap where known and traded value otherwise. Valuation shows for stocks whose results this site has read; it fills in as people open more stock pages. Prices from 19 Nov 2026.

Today: 15 minute chart and signal

Opens when you view this tab.

Analysis and next-session reading

Opens when you view this tab.

Complete analysis report Financials, shareholding, events, risks and a data reliability score.

Signals

Price is above its 50-day average 20-day average is below the 50-day (short-term downtrend) Price is above its 200-day average (long-term uptrend) RSI 64: neutral

Simple rules applied to end-of-day prices. They describe what the chart is doing and are not advice to buy or sell.

When is a good price? from this stock's own price history

The price is in the upper quarter of its 1-year range and is lower than it was on 5% of days in the past year.

Support (prices below today's)

50-day average321.18-5.3%
200-day average276.90-18.4%
20-day low275.40-18.8%
60-day low275.40-18.8%
52-week low202.85-40.2%

Resistance (prices above today's)

20-day high350.20+3.2%
60-day high378.40+11.6%
52-week high378.40+11.6%

Zones buyers often watch

Lower quarter of the 1-year range 202.85 to 246.74 Historically the cheapest part of the past year.
Pullback of 10% to 20% from the high 302.72 to 340.56 price is inside this zone now
Around the 200-day average 268.60 to 285.21 Long-term trend line, often watched as support.

Deepest fall from a peak in the past year: -28.7%. Currently -7.4% below its latest peak. Levels are from history and do not predict where the price will go.

Moving averages and momentum

IndicatorValueReading
20-day average307.76 Price is 10.2% above
50-day average321.18 Price is 5.6% above
200-day average276.90 Price is 22.5% above
RSI (14)64Neutral
MACD (12, 26, 9)6.81Above its signal line (momentum rising)
Volatility (30d)38.8%Medium yearly swings

Support and resistance

R2353.43
R1346.32
Pivot341.98
S1334.87
S2330.53

Classic pivot levels from the latest session's high, low and close. Prices often pause near them, but they are only reference points.

DateOpenHighLow CloseChangeVolume
2026-11-19 349.00 349.10 337.65 339.20 -1.21% 8,763
2026-11-18 343.30 349.00 340.00 343.35 -1.59% 22,534
2026-11-17 332.25 350.20 326.20 348.90 +6.65% 22,143
2026-11-16 324.45 329.40 315.45 327.15 +1.84% 11,695
2026-11-13 318.95 330.55 317.80 321.25 +1.34% 21,094
2026-11-12 317.60 317.70 311.60 317.00 +1.50% 11,281
2026-11-11 309.40 314.70 304.65 312.30 +1.36% 8,261
2026-11-09 316.05 316.05 307.00 308.10 -2.62% 3,805
2026-11-06 301.00 307.10 299.30 306.50 +1.74% 9,962
2026-11-05 313.90 313.90 300.00 301.25 +0.22% 6,713
2026-11-04 287.00 304.30 284.00 300.60 +5.36% 14,619
2026-11-03 285.80 286.95 283.55 285.30 +0.58% 4,795
2026-11-02 283.25 289.60 280.45 283.65 -2.93% 9,004
2026-10-30 294.60 300.95 287.80 292.20 -2.01% 12,068
2026-10-29 294.95 300.95 294.95 298.20 -0.23% 10,340
2026-10-28 298.00 299.25 295.10 298.90 -0.48% 2,743
2026-10-27 286.90 302.70 286.50 300.35 +4.60% 12,588
2026-10-26 277.00 292.00 275.40 287.15 +0.37% 16,442
2026-10-23 292.10 295.85 278.90 286.10 -3.93% 18,590
2026-10-22 303.00 303.00 293.30 297.80 -1.31% 6,685
2026-10-21 299.55 304.15 292.05 301.75 +0.08% 20,239
2026-10-19 303.80 304.00 300.00 301.50 -1.65% 5,905
2026-10-16 325.00 325.00 300.10 306.55 +1.24% 16,020
2026-10-15 300.40 305.35 300.40 302.80 +0.35% 4,684
2026-10-14 313.50 313.50 300.15 301.75 -3.04% 16,034
2026-10-13 310.45 312.70 303.40 311.20 -0.02% 12,291
2026-10-12 318.60 318.60 310.10 311.25 -0.80% 8,224
2026-10-09 309.95 315.75 309.80 313.75 +1.72% 12,302
2026-10-08 321.10 321.10 307.85 308.45 -2.99% 17,387
2026-10-07 319.95 323.65 316.30 317.95 -0.19% 18,596
2026-10-06 324.15 325.00 314.05 318.55 -1.62% 27,848
2026-10-05 337.00 341.50 322.40 323.80 -3.76% 36,373
2026-10-01 339.45 346.65 328.25 336.45 -2.68% 58,639
2026-09-30 371.65 371.65 343.00 345.70 -5.64% 41,864
2026-09-29 366.00 369.15 360.90 366.35 +0.37% 41,017
2026-09-28 361.55 372.00 351.00 365.00 +1.96% 183,806
2026-09-25 342.70 378.40 342.70 358.00 +7.57% 1,251,893
2026-09-24 340.00 342.15 331.65 332.80 -2.69% 12,870
2026-09-23 340.65 343.85 338.65 342.00 +0.21% 7,578
2026-09-22 341.50 345.95 338.45 341.30 +0.95% 15,574
2026-09-21 338.10 344.70 335.50 338.10 -0.10% 21,226
2026-09-18 334.10 344.50 334.10 338.45 +2.19% 21,504
2026-09-17 325.00 338.25 321.00 331.20 +1.55% 13,621
2026-09-16 333.00 333.00 306.40 326.15 -1.06% 34,975
2026-09-15 347.80 347.80 327.40 329.65 -4.28% 49,398
2026-09-11 348.00 351.95 339.85 344.40 -1.23% 46,005
2026-09-10 355.05 361.50 343.35 348.70 -1.64% 45,886
2026-09-09 343.00 355.90 336.10 354.50 +3.73% 36,776
2026-09-08 343.95 349.90 339.00 341.75 -0.61% 44,363
2026-09-07 338.70 344.90 332.20 343.85 +3.35% 44,819
2026-09-04 325.00 339.40 318.85 332.70 +4.03% 75,380
2026-09-03 325.10 325.10 317.00 319.80 -0.36% 10,965
2026-09-02 330.80 330.80 320.40 320.95 -2.06% 14,265
2026-09-01 321.95 334.80 315.75 327.70 +3.25% 31,363
2026-08-31 317.40 319.75 314.30 317.40 -0.60% 9,548
2026-08-28 318.60 321.25 317.35 319.30 +0.73% 11,344
2026-08-27 325.00 325.45 315.00 317.00 -1.98% 15,915
2026-08-26 329.45 329.50 322.25 323.40 -0.14% 14,589
2026-08-25 328.50 329.95 321.00 323.85 -1.43% 13,324
2026-08-24 328.05 334.05 326.50 328.55 +0.72% 32,429
2026-08-21 326.60 332.90 324.65 326.20 +1.59% 73,290
2026-08-20 313.75 326.40 313.10 321.10 +2.24% 51,175
2026-08-19 315.70 318.10 309.30 314.05 +0.64% 19,016
2026-08-18 314.10 315.00 310.00 312.05 -0.68% 7,478
2026-08-17 319.00 321.35 313.55 314.20 -0.27% 19,414
2026-08-14 320.00 320.00 312.00 315.05 -1.15% 11,826
2026-08-13 320.00 325.80 313.10 318.70 +0.70% 65,880
2026-08-12 314.05 323.00 300.60 316.50 +1.01% 56,413
2026-08-11 317.55 318.80 312.50 313.35 -0.85% 13,354
2026-08-10 317.25 325.80 313.35 316.05 -0.38% 34,545
2026-08-07 311.85 321.75 311.85 317.25 +1.75% 29,640
2026-08-06 321.80 323.75 310.00 311.80 -3.14% 29,063
2026-08-05 302.50 324.90 302.50 321.90 +6.61% 113,281
2026-08-04 305.85 308.60 299.30 301.95 -0.07% 31,630
2026-08-03 305.55 305.80 299.00 302.15 +1.58% 20,055
2026-07-31 303.20 307.20 296.40 297.45 -1.75% 40,045
2026-07-30 301.15 308.00 296.20 302.75 +1.22% 52,227
2026-07-29 281.00 305.55 277.10 299.10 +7.90% 119,857
2026-07-28 281.00 281.00 275.55 277.20 -0.45% 4,347
2026-07-27 277.20 281.55 274.60 278.45 +0.94% 12,408
2026-07-24 272.15 277.00 268.00 275.85 +1.47% 11,053
2026-07-23 270.95 274.65 270.95 271.85 -0.66% 5,356
2026-07-22 279.10 279.15 271.30 273.65 -1.25% 6,440
2026-07-21 271.50 278.00 271.00 277.10 +2.25% 5,086
2026-07-20 269.60 277.65 268.00 271.00 +0.48% 6,178
2026-07-17 274.20 277.50 267.05 269.70 -2.28% 8,343
2026-07-16 274.15 281.00 274.10 276.00 -0.07% 5,226
2026-07-15 273.70 279.25 273.70 276.20 +2.01% 4,080
2026-07-14 277.70 283.30 270.00 270.75 -2.15% 5,200
2026-07-13 274.65 278.90 271.95 276.70 -0.18% 18,434
2026-07-10 269.85 279.00 268.85 277.20 +3.43% 12,591
2026-07-09 264.00 268.70 264.00 268.00 +1.79% 2,617
2026-07-08 270.20 271.95 262.00 263.30 -3.34% 8,283
2026-07-07 276.35 278.00 271.55 272.40 -1.41% 11,610
2026-07-06 260.10 282.25 260.05 276.30 +6.11% 50,618
2026-07-03 263.55 264.55 259.30 260.40 +0.48% 3,719
2026-07-02 263.20 265.40 258.25 259.15 -1.24% 4,902
2026-07-01 265.00 266.75 260.55 262.40 -0.96% 1,743
2026-06-30 262.40 266.65 262.40 264.95 +0.89% 7,770
2026-06-29 264.35 264.35 258.35 262.60 +0.59% 4,540
2026-06-25 264.05 265.65 259.55 261.05 -1.66% 6,461
2026-06-24 263.40 271.90 263.40 265.45 -0.28% 9,278
2026-06-23 266.70 276.00 264.90 266.20 -0.89% 13,859
2026-06-22 257.00 275.20 257.00 268.60 +3.81% 14,426
2026-06-19 259.00 261.15 256.00 258.75 -0.02% 9,225
2026-06-18 265.50 265.50 257.40 258.80 -1.93% 9,538
2026-06-17 258.05 264.65 258.05 263.90 +1.00% 3,158
2026-06-16 264.90 264.90 256.00 261.30 -1.36% 9,712
2026-06-15 271.25 271.25 263.45 264.90 +0.59% 4,097
2026-06-12 262.95 264.65 258.30 263.35 +3.46% 9,249
2026-06-11 257.05 259.60 253.60 254.55 -1.70% 7,365
2026-06-10 258.65 262.50 257.20 258.95 +0.12% 7,802
2026-06-09 262.55 264.80 257.00 258.65 +0.39% 2,950
2026-06-08 267.00 269.70 256.55 257.65 -3.99% 9,280
2026-06-05 271.10 276.25 267.00 268.35 -1.12% 5,076
2026-06-04 268.00 272.90 267.90 271.40 +1.17% 3,161
2026-06-03 270.00 272.65 265.00 268.25 -1.25% 4,375
2026-06-02 269.35 272.60 261.70 271.65 +1.49% 10,648
2026-06-01 274.90 276.30 265.00 267.65 -2.53% 15,820
2026-05-29 285.70 293.00 271.15 274.60 -0.88% 11,483
2026-05-27 284.25 284.25 274.30 277.05 -2.46% 7,778
2026-05-26 291.95 291.95 282.85 284.05 -1.25% 7,220
2026-05-25 285.00 291.70 280.15 287.65 +5.10% 21,423
2026-05-22 277.60 280.30 271.65 273.70 -2.11% 15,140
2026-05-21 285.05 285.05 275.25 279.60 +0.05% 14,403
2026-05-20 272.20 281.00 266.00 279.45 +1.34% 8,623
2026-05-19 273.15 280.60 272.95 275.75 +1.10% 7,166
2026-05-18 280.60 280.85 270.40 272.75 -2.85% 10,337

News from the last 15 days More

Shareholding pattern

Up to dateNSE listingChecks passed

Quarter ended 30 Sep 2026, filed 09 Oct 2026. Latest filing is for the expected quarter (Sep 2026). Company: ARTEMIS MED SERVICE LTD, ISIN INE025R01021.

Promoters and group
58.39%
0.00 pp vs Jun 2026
Public (all, Category B)
41.61%
0.00 pp vs Jun 2026

Foreign, domestic institution and mutual fund lines need the filing file for the period. An admin can load them under Admin > Shareholding tracker.

Ownership split

Trend

Latest quarter compared

CategoryPrevious (Jun 26)Latest (Sep 26)Change (pp)Change in sharesYear earlier (pp)What it may mean
Promoters and group58.39%58.39%0.00 pp--8.14 ppNo material change.
Public (all, Category B)41.61%41.61%0.00 pp-+8.14 ppNo material change.

Change is in percentage points (latest percent minus previous percent), not a relative change. Mutual funds and insurers are part of domestic institutions and are never added to it. Only comparable quarters (1 to 6 months apart; about a year for the year-earlier column) are compared.

Insights and risk alerts

No rule was triggered by the data in the database. That is not a clean bill of health: the rules look only at reported holdings.

These alerts describe reported ownership. They are not buy or sell advice. Judge the company with its results, debt, valuation and announcements.

Who holds the shares

The exchange listing has no filing file for this stock, so holder names are not available.

Quarter by quarter

Quarter endedPromotersChangePublicChangeFiledSource
Sep 202658.39%0.00 pp41.61%0.00 pp09 Oct 2026NSE
Jun 202658.39%0.00 pp41.61%0.00 pp15 Jul 2026NSE
Mar 202658.39%0.00 pp41.61%0.00 pp14 Apr 2026NSE
Dec 202558.39%-0.04 pp41.61%+0.04 pp19 Jan 2026NSE
Nov 202558.43%-8.10 pp41.57%+8.10 pp15 Nov 2025NSE
Sep 202566.53%0.00 pp33.47%0.00 pp14 Oct 2025NSE
Jun 202566.53%-0.64 pp33.47%+0.64 pp21 Jul 2025NSE
Mar 202567.17%0.00 pp32.83%0.00 pp18 Apr 2025NSE
Dec 202467.17%0.00 pp32.83%0.00 pp13 Jan 2025NSE
Sep 202467.17%-0.34 pp32.83%+0.34 pp11 Oct 2024NSE
Jun 202467.51%-0.52 pp32.49%+0.52 pp11 Jul 2024NSE
Mar 202468.03%0.00 pp31.97%0.00 pp17 Apr 2024NSE
Dec 202368.03%0.00 pp31.97%0.00 pp16 Jan 2024NSE
Sep 202368.03%0.00 pp31.97%0.00 pp20 Oct 2023NSE
Jun 202368.03%-0.89 pp31.97%+0.89 pp21 Jul 2023NSE
Mar 202368.92%0.00 pp31.08%0.00 pp19 Apr 2023NSE
Dec 202268.92%-0.35 pp31.08%+0.35 pp12 Jan 2023NSE
Sep 202269.27%-0.32 pp30.73%+0.32 pp20 Oct 2022NSE
Jun 202269.59%-0.23 pp30.41%+0.23 pp20 Jul 2022NSE
Mar 202269.82%0.00 pp30.18%0.00 pp07 Apr 2022NSE
Dec 202169.82%0.00 pp30.18%0.00 pp12 Jan 2022NSE
Sep 202169.82%-30.18%-18 Oct 2021NSE
Shareholding details

Loading...

Events

Not checked yet

BSE events come from the BSE corporate actions file, which an admin uploads. There is no automatic BSE fetch. Nothing has been imported for this stock yet.

No events saved for this stock yet.

Fetched from NSE automatically and saved on this site, so past events stay available. Ex date is the first day the stock trades without the benefit; a bonus or split is applied to old prices on its own from that day. Confirm on the exchange website before acting.

ISA shows information and signals worked out from past prices and company filings. They are not recommendations to buy, sell or hold any security, and ISA is not a SEBI-registered investment adviser or research analyst. Prices may be delayed. Check with a registered adviser before you invest.